HROW Harrow, Inc.

HROW Harrow, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

Market read

Scan convergence 2 scans as of 2026-08-17 2 neutral converging

POC $40.05 · VWAP $40.37 · -2.2% vs 12m avg buyer

pullback vol: normalgaps: overnight-shiftchurn: quiet as of

Insiders no data — outside the Form 4 poll — US-filer feed only (foreign filers report via MAR managers'-transactions notices)

Coverage

1 watchlist

Watchlists @healthcare

HROW Price Structure

Loading chart…

Loading timeframes…

Peers

Every watchlist HROW belongs to, members best 30-day change first — HROW highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.

Next earnings HROW reports in 83 days Nov 9

Last report Aug 10

COVERAGE GAP — this name's print date has passed and tonight's bounded news pass (~25 marquee/tracked symbols) did not include it. No coverage was acquired; nothing is asserted about the result. Refill on the next daily or when the name earns a targeted pull.

full note →

Against street estimates

How HROW's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.

8 most recent of 10 quarters · newest report Aug 10 · projection Aug 17

Result
Aug 10 -0.24-0.46-91.7%Miss
May 11 -0.33-0.74-124.2%Miss
Mar 2 0.370.17-53.6%Miss
Nov 10 '25 0.290.33 GAAP ≠ +13.8%Beat
Aug 11 '25 0.040.24 GAAP ≠ +585.7%Beat
May 8 '25 0.01-0.38-5797.1%Miss
Mar 27 '25 0.130.40+207.7%Beat
Nov 13 '24 0.07-0.05-171.4%Miss